Accueil Ernstrade Bourse
plus500
 
Place: Copenhagen Stock Exchange

Danske Invest Bioteknologi (the Fund) is a Denmark-based investment fund. It is primarily engaged in making specialty investments globally in the equities of biotechnology companies, basing its investments on the AMEX Biotech index. As of February 28, 2010, 99% of the Fund’s investments were located in companies based or active in the United States, and included companies such as Sequenom Inc., Millipore Corporation, Amylin Pharmaceuticals Inc., Affymetrix Inc. and Cephalon Inc., as well as other companies. Danske Invest Bioteknologi is managed by Danske Capital division of Danske Bank A/S and is a division of Investeringsforeningen Danske Invest, a shareholder association based in Denmark

http://www.danskeinvest.dk/
 
 
 
 
 

 


Copyright   2010 Ernstrade.com